Logo image of ATEME.PA

ATEME SA (ATEME.PA) Stock Fundamental Analysis

EPA:ATEME - Euronext Paris - Matif - FR0011992700 - Common Stock - Currency: EUR

4.04  -0.06 (-1.46%)

Fundamental Rating

2

ATEME gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 26 industry peers in the Communications Equipment industry. ATEME has a bad profitability rating. Also its financial health evaluation is rather negative. ATEME has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ATEME had negative earnings in the past year.
ATEME had a negative operating cash flow in the past year.
In multiple years ATEME reported negative net income over the last 5 years.
In multiple years ATEME reported negative operating cash flow during the last 5 years.
ATEME.PA Yearly Net Income VS EBIT VS OCF VS FCFATEME.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M 6M -6M

1.2 Ratios

ATEME has a Return On Assets (-9.12%) which is in line with its industry peers.
The Return On Equity of ATEME (-29.49%) is worse than 61.54% of its industry peers.
Industry RankSector Rank
ROA -9.12%
ROE -29.49%
ROIC N/A
ROA(3y)-0.84%
ROA(5y)1.05%
ROE(3y)-2.58%
ROE(5y)1.69%
ROIC(3y)N/A
ROIC(5y)N/A
ATEME.PA Yearly ROA, ROE, ROICATEME.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 -20

1.3 Margins

ATEME has a Gross Margin of 58.70%. This is in the better half of the industry: ATEME outperforms 69.23% of its industry peers.
ATEME's Gross Margin has improved in the last couple of years.
ATEME does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 58.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.85%
GM growth 5Y3.95%
ATEME.PA Yearly Profit, Operating, Gross MarginsATEME.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

ATEME does not have a ROIC to compare to the WACC, probably because it is not profitable.
ATEME has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ATEME has more shares outstanding
The debt/assets ratio for ATEME is higher compared to a year ago.
ATEME.PA Yearly Shares OutstandingATEME.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
ATEME.PA Yearly Total Debt VS Total AssetsATEME.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

ATEME has an Altman-Z score of 1.42. This is a bad value and indicates that ATEME is not financially healthy and even has some risk of bankruptcy.
ATEME's Altman-Z score of 1.42 is in line compared to the rest of the industry. ATEME outperforms 53.85% of its industry peers.
ATEME has a Debt/Equity ratio of 0.77. This is a neutral value indicating ATEME is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.77, ATEME is not doing good in the industry: 69.23% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF N/A
Altman-Z 1.42
ROIC/WACCN/A
WACC5.28%
ATEME.PA Yearly LT Debt VS Equity VS FCFATEME.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M 40M

2.3 Liquidity

ATEME has a Current Ratio of 1.55. This is a normal value and indicates that ATEME is financially healthy and should not expect problems in meeting its short term obligations.
ATEME has a Current ratio of 1.55. This is comparable to the rest of the industry: ATEME outperforms 42.31% of its industry peers.
ATEME has a Quick Ratio of 1.37. This is a normal value and indicates that ATEME is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ATEME (1.37) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.37
ATEME.PA Yearly Current Assets VS Current LiabilitesATEME.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for ATEME have decreased strongly by -176.02% in the last year.
Looking at the last year, ATEME shows a decrease in Revenue. The Revenue has decreased by -5.28% in the last year.
Measured over the past years, ATEME shows a quite strong growth in Revenue. The Revenue has been growing by 12.11% on average per year.
EPS 1Y (TTM)-176.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-148.55%
Revenue 1Y (TTM)-5.28%
Revenue growth 3Y12.24%
Revenue growth 5Y12.11%
Sales Q2Q%-16.99%

3.2 Future

ATEME is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 49.76% yearly.
Based on estimates for the next years, ATEME will show a small growth in Revenue. The Revenue will grow by 3.71% on average per year.
EPS Next Y-16.3%
EPS Next 2Y59.82%
EPS Next 3Y49.76%
EPS Next 5YN/A
Revenue Next Year-6.75%
Revenue Next 2Y0.95%
Revenue Next 3Y3.71%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ATEME.PA Yearly Revenue VS EstimatesATEME.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
ATEME.PA Yearly EPS VS EstimatesATEME.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4 -0.4 0.6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

ATEME reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 15.38, the valuation of ATEME can be described as correct.
ATEME's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ATEME is cheaper than 65.38% of the companies in the same industry.
ATEME is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 15.38
ATEME.PA Price Earnings VS Forward Price EarningsATEME.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ATEME.PA Per share dataATEME.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A more expensive valuation may be justified as ATEME's earnings are expected to grow with 49.76% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y59.82%
EPS Next 3Y49.76%

More info and screens

0

5. Dividend

5.1 Amount

ATEME does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ATEME SA

EPA:ATEME (3/7/2025, 7:00:00 PM)

4.04

-0.06 (-1.46%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)10-17 2024-10-17
Earnings (Next)03-19 2025-03-19/amc
Inst Owners28.44%
Inst Owner ChangeN/A
Ins Owners20.5%
Ins Owner ChangeN/A
Market Cap46.42M
Analysts86
Price Target7.65 (89.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.23%
PT rev (3m)-3.23%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-105.77%
EPS NY rev (3m)-105.77%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-4.85%
Revenue NY rev (3m)-4.85%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 15.38
P/S 0.51
P/FCF N/A
P/OCF N/A
P/B 1.53
P/tB 8.57
EV/EBITDA N/A
EPS(TTM)-0.78
EYN/A
EPS(NY)0.26
Fwd EY6.5%
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS7.98
BVpS2.65
TBVpS0.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.12%
ROE -29.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 58.7%
FCFM N/A
ROA(3y)-0.84%
ROA(5y)1.05%
ROE(3y)-2.58%
ROE(5y)1.69%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.85%
GM growth 5Y3.95%
F-Score1
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 71.25%
Cap/Sales 3.24%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 1.37
Altman-Z 1.42
F-Score1
WACC5.28%
ROIC/WACCN/A
Cap/Depr(3y)57.23%
Cap/Depr(5y)53.99%
Cap/Sales(3y)2.59%
Cap/Sales(5y)2.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-176.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-148.55%
EPS Next Y-16.3%
EPS Next 2Y59.82%
EPS Next 3Y49.76%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.28%
Revenue growth 3Y12.24%
Revenue growth 5Y12.11%
Sales Q2Q%-16.99%
Revenue Next Year-6.75%
Revenue Next 2Y0.95%
Revenue Next 3Y3.71%
Revenue Next 5YN/A
EBIT growth 1Y-418.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year165.35%
EBIT Next 3Y70.09%
EBIT Next 5YN/A
FCF growth 1Y-668.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-430.72%
OCF growth 3Y-52.89%
OCF growth 5Y-34.92%